# Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations

Source: https://onco.cc/trials/nct06674343/  
OnCo record `nct06674343` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of furmonertinib in lung cancer, run by Peking Union Medical College Hospital, now recruiting.

## Summary

Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations is a phase 3, interventional study registered as NCT06674343 by Peking Union Medical College Hospital, with a registry enrolment figure of 144 participants, started 2024-07-15 and due to reach its primary completion in 2026-12-31. Interventions recorded: Furmonertinib. Conditions listed: Advanced or Metastatic Non-small Cell Lung Cancer. Primary outcome: Progression Freae Survival (PFS). Lung eligibility wording from the registry: "* Histologically or cytologically confirmed locally advanced or metastatic lung adenocarcinoma not amenable to curative surgery or radiotherapy;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06674343
- Phase: 3
- Setting: The Efficacy and Safety of Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With EGFR Classical Mutations, a Prospective, Single-arm, Multicenter Clinical Study
- Sponsor: Peking Union Medical College Hospital
- Enrolled: 144

## Sources

- ClinicalTrials.gov NCT06674343: https://clinicaltrials.gov/study/NCT06674343

## Connected records

- cancers: [EGFR-mutated non-small-cell lung cancer](https://onco.cc/cancers/egfr-mutant-nsclc/)
- technologies: [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Furmonertinib](https://onco.cc/drugs/furmonertinib/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06674343.json